This invention provides a method for preparing a medical-grade high-transparency collagen solution, comprising the following steps: S1. Fresh animal tissue is taken, and after
removing hair,
fascia, fat, and
flesh, it is sliced, washed to
remove blood, washed with water, and freeze-pulverized; S2. The pulverized material is soaked in a mixed
defatting agent for
defatting; the mixed
defatting agent includes a cationic surfactant and a
lipase, wherein the cationic surfactant includes at least one of a bio-based surfactant and a
quaternary ammonium salt surfactant; the bio-based surfactant includes at least one of
rhamnolipid,
sophorolipid, and
trehalose; S3. The defatted material is frozen, irradiated, then soaked in
purified water, filtered, and the swollen material is collected; S4. The swollen material is enzymatically hydrolyzed; S5. The filtrate after
enzymatic hydrolysis is collected, salted out, filtered, and the residue is collected, then washed in a
salt solution to obtain the salted-out material; S6. The salted-out material is dissolved in pure water, and the collagen
protein mass fraction is controlled at 0.01-6.5%, then
ultrafiltration is performed, the filtrate is collected, and stored at low temperature to obtain a collagen solution. The collagen prepared by this method has high transparency, and its structure remains intact during the preparation process, meaning the final collagen solution retains its complete
triple helix structure. Furthermore, the entire extraction process does not involve the addition of
heavy metals or toxic reagents, thus eliminating the risk of heavy
metal or toxic
reagent residues and broadening its application range.